These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 7678942)
1. [Seroprevalence of hepatitis C virus in hemophiliacs in Switzerland]. Perret BA; Senn M; Affentranger P; Poorbeik M; Burckhardt JJ; Morell A Schweiz Med Wochenschr; 1993 Jan; 123(3):79-81. PubMed ID: 7678942 [TBL] [Abstract][Full Text] [Related]
2. [Hepatitis C antibodies in children and adolescents with congenital blood coagulation disorders]. Zenz W; Hofmann H; Muntean W Wien Klin Wochenschr; 1991; 103(3):69-72. PubMed ID: 1851352 [TBL] [Abstract][Full Text] [Related]
3. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. Kupfer B; Ruf T; Matz B; Nattermann J; Spengler U; Rockstroh JK; Brackmann HH; Blümel J; Tacke M; Kaiser R J Clin Virol; 2005 Sep; 34(1):42-7. PubMed ID: 16087123 [TBL] [Abstract][Full Text] [Related]
4. [Hepatitis A antibodies in young hemophiliacs]. Schiller WG; Doroshenko NW; Stakhanova VM; Remde W Z Gesamte Inn Med; 1985 Mar; 40(6):183-5. PubMed ID: 3873754 [TBL] [Abstract][Full Text] [Related]
5. [No HCV seroconversion in hemophilia following substitution with virus-inactivated coagulation factor VIII and IX concentrates]. Perret BA; Morell A; Bütler-Brunner E; Burckhardt JJ Schweiz Med Wochenschr; 1991 Nov; 121(44):1621-3. PubMed ID: 1658928 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of hepatitis C virus antibodies and genotypes in asymptomatic, first-time blood donors in Namibia. Vardas E; Sitas F; Seidel K; Casteling A; Sim J Bull World Health Organ; 1999; 77(12):965-72. PubMed ID: 10680243 [TBL] [Abstract][Full Text] [Related]
7. Hepatitis C (HCV) genotype and viral titer distribution among Argentinean hemophilic patients in the presence or absence of human immunodeficiency virus (HIV) co-infection. Picchio GR; Nakatsuno M; Boggiano C; Sabbe R; Corti M; Daruich J; Pérez-Bianco R; Tezanos-Pinto M; Kokka R; Wilber J; Mosier D J Med Virol; 1997 Jun; 52(2):219-25. PubMed ID: 9179772 [TBL] [Abstract][Full Text] [Related]
8. Detection of antibodies to HCV: comparison of a c100-3 EIA and the 2nd generation EIA. Polywka S; Kaars-Wiele P; Schroeter E; Mandler J; Laufs R Beitr Infusionsther; 1992; 30():42-5. PubMed ID: 1284750 [TBL] [Abstract][Full Text] [Related]
9. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide]. Sugiyasu T Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127 [TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT; Wang TH; Sheu JC; Tsai SJ; Hsieh YS; Lin DT; Wang CY; Chen DS Arch Pathol Lab Med; 1993 Feb; 117(2):152-6. PubMed ID: 8381269 [TBL] [Abstract][Full Text] [Related]
11. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study. Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431 [TBL] [Abstract][Full Text] [Related]
12. [Antibodies against hepatitis C virus in hemophiliacs: correlation with peripheral blood lymphocyte populations]. Gómez E; Alberca I; Vicente V; González M; Martín AM; Corral M; Cordero M; López Borrasca A Med Clin (Barc); 1991 Jan; 96(3):81-4. PubMed ID: 1851910 [TBL] [Abstract][Full Text] [Related]
13. Detection of antibodies to hepatitis C virus: false-negative results in an automated chemiluminescent microparticle immunoassay (ARCHITECT Anti-HCV) compared to a microparticle enzyme immunoassay (AxSYM HCV Version 3.0). Myrmel H; Navaratnam V; Asjø B J Clin Virol; 2005 Nov; 34(3):211-5; discussion 216-8. PubMed ID: 16112611 [TBL] [Abstract][Full Text] [Related]
14. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein. Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782 [TBL] [Abstract][Full Text] [Related]
15. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients. Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
17. A focus reduction neutralization assay for hepatitis C virus neutralizing antibodies. Fournier C; Duverlie G; François C; Schnuriger A; Dedeurwaerder S; Brochot E; Capron D; Wychowski C; Thibault V; Castelain S Virol J; 2007 Mar; 4():35. PubMed ID: 17397531 [TBL] [Abstract][Full Text] [Related]
18. Serological markers of autoimmunity in patients with hemophilia A: the role of hepatitis C virus infection, alpha-interferon and factor VIII treatment in skewing the immune system toward autoreactivity. Vianello F; Tison T; Tagariello G; Zerbinati P; Zanon E; Scarano L; Girolami A Blood Coagul Fibrinolysis; 1999 Sep; 10(6):393-7. PubMed ID: 10493222 [TBL] [Abstract][Full Text] [Related]
20. Prevalence of hepatitis B and C seromarkers and abnormal liver function tests among hemophiliacs in Guilan (northern province of Iran). Mansour-Ghanaei F; Fallah MS; Shafaghi A; Yousefi-Mashhoor M; Ramezani N; Farzaneh F; Nassiri R Med Sci Monit; 2002 Dec; 8(12):CR797-800. PubMed ID: 12503038 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]